For citations:
Pavlov A.I., Kirillov S.M., Ponomarenko D.S., Havanshanov A.K., Fadina J.V., Bobkova I.V., Vasenko V.I., Volodina G.A., Kulikova T.Yu., Linkova Yu.N., Morozova M.A. Efficacy and safety of сepeginterferon alfa-2b in double treatment regimen (cepeginterferon alfa-2b and ribavirin) of antiviral therapy in patients with chronic hepatitis C genotypes 2 and 3. Experience of real clinical practice. Journal Infectology. 2016;8(3):92-98. (In Russ.)